Shed syndecan-2 inhibits angiogenesis

Journal of Cell Science

Volumn 127, Issue 21, 2014, Pages 4788-4799

  Rossi, Giulia De ^a   Evans, Alun R ^a   Kay, Emma ^a   Woodfin, Abigail ^a   McKay, Tristan R ^b   Nourshargh, Sussan ^a   Whiteford, James R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Angiogenesis; Endothelial cell migration; Inflammation; Integrin; Syndecan

Indexed keywords

BETA1 INTEGRIN; CD148 ANTIGEN; CORE PROTEIN; HYBRID PROTEIN; PROTEIN TYROSINE PHOSPHATASE; SHED SYNDECAN 2; SYNDECAN 2; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HEK293 CELL LINE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PROTEIN FUNCTION; PROTEIN INTERACTION; ANIMAL; CELL CULTURE; CELL MOTION; DRUG SCREENING; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGY; SCID MOUSE;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; MICE; MICE, SCID; NEOVASCULARIZATION, PATHOLOGIC; SYNDECAN-2; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84913534106     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.153015     Document Type: Article

References (36)

1. Beauvais, D. M. and Rapraeger, A. C. (2010). Syndecan-1 couples the insulinlike growth factor-1 receptor to inside-out integrin activation. J. Cell Sci. 123, 3796-3807.
2. Beauvais, D. M., Burbach, B. J. and Rapraeger, A. C. (2004). The syndecan-1 ectodomain regulates alphavbeta3 integrin activity in human mammary carcinoma cells. J. Cell Biol. 167, 171-181.
3. Beauvais, D. M., Ell, B. J., McWhorter, A. R. and Rapraeger, A. C. (2009). Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor. J. Exp. Med. 206, 691-705.
4. Carmeliet, P. (2003). Angiogenesis in health and disease. Nat. Med. 9, 653-660.
5. Chen, E., Hermanson, S. and Ekker, S. C. (2003). Syndecan-2 is essential for angiogenic sprouting during zebrafish development. Blood 103, 1710-1719.
6. de la Fuente-García, M. A., Nicolás, J. M., Freed, J. H., Palou, E., Thomas, A. P., Vilella, R., Vives, J. and Gayá, A. (1998). CD148 is a membrane protein tyrosine phosphatase present in all hematopoietic lineages and is involved in signal transduction on lymphocytes. Blood 91, 2800-2809.
7. De Rossi, G. and Whiteford, J. R. (2013a). Novel insight into the biological functions of syndecan ectodomain core proteins. Biofactors 39, 374-382.
8. De Rossi, G. and Whiteford, J. R. (2013b). A novel role for syndecan-3 in angiogenesis. F1000Res. 2, 270.
9. De Rossi, G., Scotland, R. and Whiteford, J. (2013). Critical factors in measuring angiogenesis using the aortic ring model. J. Genet. Syndr. Gene Ther. 4, 1000147.
10. Duda, D. G., Batchelor, T. T., Willett, C. G. and Jain, R. K. (2007). VEGFtargeted cancer therapy strategies: current progress, hurdles and future prospects. Trends Mol. Med. 13, 223-230.
11. Fears, C. Y., Gladson, C. L. and Woods, A. (2006). Syndecan-2 is expressed in the microvasculature of gliomas and regulates angiogenic processes in microvascular endothelial cells. J. Biol. Chem. 281, 14533-14536.
12. Ishiguro, K., Kojima, T. and Muramatsu, T. (2002). Syndecan-4 as a molecule involved in defense mechanisms. Glycoconj. J. 19, 315-318.
13. Kwon, M. J., Hong, E., Choi, Y., Kang, D. H. and Oh, E. S. (2014). Interleukin-1a promotes extracellular shedding of syndecan-2 via induction of matrix metalloproteinase-7 expression. Biochem. Biophys. Res. Commun. 446, 487-492.
14. Manon-Jensen, T., Itoh, Y. and Couchman, J. R. (2010). Proteoglycans in health and disease: the multiple roles of syndecan shedding. FEBS J. 277, 3876-3889.
15. Manon-Jensen, T., Multhaupt, H. A. and Couchman, J. R. (2013). Mapping of MMP cleavage sites on syndecan-1 and syndecan-4 ectodomains. FEBS J. 280, 2320-2331.
16. Mapp, P. I. and Walsh, D. A. (2012). Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nat. Rev. Rheumatol. 8, 390-398.
17. McFall, A. J. and Rapraeger, A. C. (1997). Identification of an adhesion site within the syndecan-4 extracellular protein domain. J. Biol. Chem. 272, 12901-12904.
18. McFall, A. J. and Rapraeger, A. C. (1998). Characterization of the high affinity cell-binding domain in the cell surface proteoglycan syndecan-4. J. Biol. Chem. 273, 28270-28276.
19. Mettouchi, A. and Meneguzzi, G. (2006). Distinct roles of beta1 integrins during angiogenesis. Eur. J. Cell Biol. 85, 243-247.
20. Nicosia, R. F. and Ottinetti, A. (1990). Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. Lab. Invest. 63, 115-122.
21. Passaniti, A., Taylor, R. M., Pili, R., Guo, Y., Long, P. V., Haney, J. A., Pauly, R. R., Grant, D. S. and Martin, G. R. (1992). A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement-membrane, heparin, and fibroblast growth-factor. Lab. Invest. 67, 519-528.
22. Pruessmeyer, J., Martin, C., Hess, F. M., Schwarz, N., Schmidt, S., Kogel, T., Hoettecke, N., Schmidt, B., Sechi, A., Uhlig, S. et al. (2010). A disintegrin and metalloproteinase 17 (ADAM17) mediates inflammation-induced shedding of syndecan-1 and-4 by lung epithelial cells. J. Biol. Chem. 285, 555-564.
23. Ramjaun, A. R. and Hodivala-Dilke, K. (2009). The role of cell adhesion pathways in angiogenesis. Int. J. Biochem. Cell Biol. 41, 521-530.
24. Rapraeger, A. C., Ell, B. J., Roy, M., Li, X., Morrison, O. R., Thomas, G. M. and Beauvais, D. M. (2013). Vascular endothelial-cadherin stimulates syndecan-1-coupled insulin-like growth factor-1 receptor and cross-talk between aVb3 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenesis. FEBS J. 280, 2194-2206.
25. Reynolds, L. E., Wyder, L., Lively, J. C., Taverna, D., Robinson, S. D., Huang, X., Sheppard, D., Hynes, R. O. and Hodivala-Dilke, K. M. (2002). Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat. Med. 8, 27-34.
26. Sakurai, T. and Kudo, M. (2011). Signaling pathways governing tumor angiogenesis. Oncology 81 Suppl. 1, 24-29.
27. Streuli, C. H. and Akhtar, N. (2009). Signal co-operation between integrins and other receptor systems. Biochem. J. 418, 491-506.
28. Takahashi, T., Takahashi, K., St John, P. L., Fleming, P. A., Tomemori, T., Watanabe, T., Abrahamson, D. R., Drake, C. J., Shirasawa, T. and Daniel, T. O. (2003). A mutant receptor tyrosine phosphatase, CD148, causes defects in vascular development. Mol. Cell. Biol. 23, 1817-1831.
29. Takahashi, T., Takahashi, K., Mernaugh, R. L., Tsuboi, N., Liu, H. and Daniel, T. O. (2006). A monoclonal antibody against CD148, a receptor-like tyrosine phosphatase, inhibits endothelial-cell growth and angiogenesis. Blood 108, 1234-1242.
30. Takahashi, K., Mernaugh, R. L., Friedman, D. B., Weller, R., Tsuboi, N., Yamashita, H., Quaranta, V. and Takahashi, T. (2012). Thrombospondin-1 acts as a ligand for CD148 tyrosine phosphatase. Proc. Natl. Acad. Sci. USA 109, 1985-1990.
31. Trapasso, F., Drusco, A., Costinean, S., Alder, H., Aqeilan, R. I., Iuliano, R., Gaudio, E., Raso, C., Zanesi, N., Croce, C. M. et al. (2006). Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis. DNA Cell Biol. 25, 376-382.
32. Whiteford, J. R. and Couchman, J. R. (2006). A conserved NXIP motif is required for cell adhesion properties of the syndecan-4 ectodomain. J. Biol. Chem. 281, 32156-32163.
33. Whiteford, J. R., Behrends, V., Kirby, H., Kusche-Gullberg, M., Muramatsu, T. and Couchman, J. R. (2007). Syndecans promote integrin-mediated adhesion of mesenchymal cells in two distinct pathways. Exp. Cell Res. 313, 3902-3913.
34. Whiteford, J. R., Xian, X., Chaussade, C., Vanhaesebroeck, B., Nourshargh, S. and Couchman, J. R. (2011). Syndecan-2 is a novel ligand for the protein tyrosine phosphatase receptor CD148. Mol. Biol. Cell 22, 3609-3624.
35. Zhu, J. W., Brdicka, T., Katsumoto, T. R., Lin, J. and Weiss, A. (2008). Structurally distinct phosphatases CD45 and CD148 both regulate B cell and macrophage immunoreceptor signaling. Immunity 28, 183-196.
36. Zhu, J. W., Doan, K., Park, J., Chau, A. H., Zhang, H., Lowell, C. A. and Weiss, A. (2011). Receptor-like tyrosine phosphatases CD45 and CD148 have distinct functions in chemoattractant-mediated neutrophil migration and response to S. aureus. Immunity 35, 757-769.